fashion -WSS

fashion

author：focus 2025-10-01 17:42:53 - browse：7919

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Living with Fabry disease, a condition that causes chronic pain

WSS

Retired US general questions alleged Putin, Prigozhin meeting

Why 40% Americans with Parkinson’s don’t see a neurologist

Boston Scientific acquires urology company Axonics for $3.7 billion

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Stories you might have missed in 2023: health, science, medicine

entertainment

fashion

focus

In age of alternative facts, a scholarly course on calling out crap

Life science postdocs should get big pay hike, NIH panel says

How one medical school became remarkably diverse

FDA early review: GLP

What does generative AI mean for health care? We asked experts

Petition to FDA: Get the lead out of consumer hair dyes

Affirmative action in medical school literally saved lives

Arena BioWorks launches in Cambridge to speed drug discovery

Heart attack and stroke risk calculators need revising

Retired US general questions alleged Putin, Prigozhin meeting

hotspot

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

A new study sees potential in DNA sequencing of infants

New research casts further doubt on a common procedure used with IVF

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Study suggests new cause of Down syndrome: cells linked to aging

entertainment

entertainment

hotspot

hotspot